EDWARD M FITZGERALD
CIK 1242993 · Executive VP · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
44
Lifetime Open-Market Net
-$4.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PBLS | Director | 14,688 | — | — | $0 | 2 | 2026-06-15 |
| AKCEA THERAPEUTICS, INC. (AKCA) Delisted | Director | — | — | — | $0 | 2 | 2019-06-18 |
| ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Executive VP | 325,784 | — | — | -$4.70M | 40 | 2016-03-22 |
Recent Filings · Page 2 of 5
44 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-16 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +7,000 | -$59.8K | EDGAR |
| 2015-05-04 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | — | -$74.4K | EDGAR |
| 2015-04-30 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-23 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +9,582 | -$83.5K | EDGAR |
| 2015-02-04 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +14,667 | -$92.8K | EDGAR |
| 2014-09-04 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | — | -$24.7K | EDGAR |
| 2014-07-17 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +9,436 | -$25.4K | EDGAR |
| 2014-03-21 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Mixed | +13,015 | -$50.2K | EDGAR |
| 2014-02-04 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-12-20 | ARIAD PHARMACEUTICALS INC (ARIA) Delisted | Exer (M) | +19,500 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.